famotidine has been researched along with Cholestasis, Intrahepatic in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ament, PW | 1 |
| Roth, JD | 1 |
| Fox, CJ | 1 |
1 other study available for famotidine and Cholestasis, Intrahepatic
| Article | Year |
|---|---|
Famotidine-induced mixed hepatocellular jaundice.
Topics: Cholestasis, Intrahepatic; Famotidine; Humans; Male; Middle Aged | 1994 |